Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Chemed Corporation Declares Quarterly Dividend of 40 Cents
Chemed Corporation Declares Quarterly Dividend of 40 Cents


Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company’s capital stock, payable on March 15, 2024, to

EQS-News: M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024
EQS-News: M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024
EQS-News: M1 Kliniken AG: Private equity interested in beauty segment, EBITDA of over EUR 27 million expected in 2024
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
 Sartorius Stedim Biotech releases Universal Registration Document 2023
Sartorius Stedim Biotech releases Universal Registration Document 2023
Sartorius Stedim Biotech releases Universal Registration Document 2023
Sartorius Stedim Biotech: Information on Document Availability
Sartorius Stedim Biotech: Information on Document Availability
Sartorius Stedim Biotech: Information on Document Availability
PINC AI™ and Fortune Name the Nation’s 50 Top Cardiovascular Hospitals™
PINC AI™ and Fortune Name the Nation’s 50 Top Cardiovascular Hospitals™


PINC AI, the technology and services brand of Premier, Inc. (NASDAQ: PINC), today announced the nation’s 50 Top Cardiovascular Hospitals. The full list of recognized hospitals was published in an

Simulations Plus Extends Collaboration with Major Toxicology Research Agency
Simulations Plus Extends Collaboration with Major Toxicology Research Agency


Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries

Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28
Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28


Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2023, on Tuesday, February 27, 2024, following the close of trading

QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results: https://s24.q4cdn.com/594651504/files/design/QO_Logo_FINAL.png
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results


QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and

Agilent Ranked Among Top 50 Most Just Companies in AmericaPhoto, wide shot, wide-angle lens, soft focus,  Amusement park, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-9ykfBOFTwqbOHnaukQ2bUqdm.png?st=2023-05-13T13%3A50%3A52Z&se=2023-05-13T15%3A50%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-12T20%3A43%3A22Z&ske=2023-05-13T20%3A43%3A22Z&sks=b&skv=2021-08-06&sig=G2Gltvd1Lg2exXRILeKuP5%2BTSWMna0SOjxb75jCyrG0%3D
Agilent Ranked Among Top 50 Most Just Companies in America


Agilent Technologies Inc. (NYSE: A) today announced the company was again named one of the Most JUST Companies in America by Just Capital and CNBC. This marks the sixth year Agilent has appeared on

Simulations Plus Launches Corporate Development Initiative
Simulations Plus Launches Corporate Development Initiative


Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today provided additional

Premier, Inc.’s PINC AI™ Applied Sciences and Datavant Collaborate to Enable Next-Generation Clinical Trials
Premier, Inc.’s PINC AI™ Applied Sciences and Datavant Collaborate to Enable Next-Generation Clinical Trials


PINC AI™ Applied Sciences (PAS), a division of Premier, Inc. (NASDAQ: PINC), and Datavant, the company that protects, connects and delivers the world’s health data, announce the companies are

Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call
Owens & Minor Announces Fourth Quarter 2023 Earnings Release Date and Conference Call


Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the fourth quarter of 2023 on Tuesday, February 20, 2024, before trading begins on the New York Stock Exchange.



The Company

Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results


DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023.



Fourth Quarter 2023 Financial Highlights:




  • Revenue grew 27%

Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products:
Agilent Wins Two Scientists’ Choice Awards for Drug Discovery and Development Products


Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery &amp

Agilent to Participate in TD Cowen Health Care Conference
Agilent to Participate in TD Cowen Health Care Conference


Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday

Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2023 Earnings Release
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2023 Earnings Release


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2023 results on Tuesday, February 27, 2024, after the close of the market. Acadia

Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
Humana Releases Results from Innovative Health Literacy and Healthcare Discrimination Screenings Pilot
Humana Releases Results from Innovative Health Literacy and Healthcare Discrimination Screenings Pilot


Humana Inc. (NYSE: HUM), a leading U.S. health insurer and healthcare services company, continues to make strides in advancing health equity by releasing the findings of its new pilot study

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech S.A. successfully completes a EUR 1.2 billion share capital increase without shareholders’ preferential subscription rights
Edwards Lifesciences Reports Fourth Quarter Results:
Edwards Lifesciences Reports Fourth Quarter Results


Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended December 31, 2023.



Highlights and Outlook




  • Q4 sales grew 14 percent to $1.53 billion; constant currency1

Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Sartorius Stedim Biotech S.A. announces an offering of approximately 1.2 billion euros of new shares without shareholders’ preferential subscription rights by means of an accelerated bookbuilding
Simulations Plus to Participate in Upcoming Healthcare Conferences
Simulations Plus to Participate in Upcoming Healthcare Conferences


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it will participate in two

Premier, Inc. Reports Fiscal-Year 2024 Second-Quarter Results
Premier, Inc. Reports Fiscal-Year 2024 Second-Quarter Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 second quarter ended December 31, 2023.



"Our

Premier, Inc. Completes Strategic Review Process
Premier, Inc. Completes Strategic Review Process


Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Company”), a leading technology-driven healthcare improvement company, today announced that the Company’s Board of Directors has concluded its